Skip to content

Screening for Inherited Heart Disease

Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001746
Enrollment
Unknown
Registered
1999-11-04
Start date
1998-04-30
Completion date
2003-04-30
Last updated
2008-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Disease, Hypertrophic Cardiomyopathy

Keywords

Hypertrophic Cardiomyopathy, HCM, Evaluation for Research, Medical Advice

Brief summary

Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Presently, there are several research studies being conducted in order to improve the understanding of disease processes and symptoms associated with genetically inherited heart diseases. This study is designed to determine the eligibility of patients diagnosed with or suspected to have inherited heart disease to participate in these research studies.

Detailed description

Patients with hypertrophic cardiomyopathy (HCM) and other inherited cardiac diseases are being studied under several research protocols to determine their pathogenesis and clinical manifestations. The purpose of this protocol is to determine the eligibility of patients with known or suspected inherited heart conditions for our research protocols.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Subjects and family members known or suspected to have inherited a cardiac disease such as HCM.

Exclusion criteria

Patients with cardiac conditions that are not known to be inherited.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026